EP MedSystems, EchoCath bury hatchet

AuntMinnie.com staff writers
Jan 7, 2002

Cardiac electrophysiology developer EP MedSystems (EPMD) and ultrasound technology developer EchoCath have settled their legal differences. The litigation, which was initiated by Mt. Arlington, NJ-based EPMD 1998, was settled for a cash payment to EPMD of $30,000.

EPMD also agreed to convert its EchoCath preferred stock into 300,000 shares of the Princeton, NJ-based vendor's common stock and warrants. In addition, EPMD received a nonexclusive license to seven EchoCath patents covering ultrasound imaging technology.

EPMD has developed an ultrasound imaging catheter to provide high-resolution images of the interior anatomy of the heart, according to the firm.

By AuntMinnie.com staff writers
January 8, 2002

Related Reading

EPMD to distribute Fischer fluoro units, May 9, 2001

EchoCath retains investment advisor, May 1, 2001

EchoCath gets OK for EchoFlow, March 26, 2001

Morton named EchoCath VP, January 10, 2001

Copyright © 2002 AuntMinnie.com

Latest in Ultrasound
Ultrasound Scanner Computerized 400 (1)
CEUS-based radiomics model aids in breast cancer diagnosis
November 26, 2024
Thyroid 400
Ultrasound-based deep learning models aid thyroid nodule prediction
November 25, 2024
Back Pain 400
Elastography shows tissue stiffness in athletes with low-back pain
November 22, 2024
Ovarian Cancer Social
Nomogram model predicts malignancy risk in ovarian masses
November 19, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2001 12 17 15 22 00 706
Ultrasound
3-D ultrasound of fetal brain aids focused postnatal management
2001 12 13 15 18 35 706
Ultrasound
Ultrasound disappoints in abdominal trauma
2001 11 12 10 40 09 706
Ultrasound
Adenomyosis: Making the diagnosis with ultrasound
More in Ultrasound
CEUS-based radiomics model aids in breast cancer diagnosis
By Amerigo Allegretto
A contrast-enhanced ultrasound (CEUS)-based radiomics model could help accurately diagnose breast cancer.
November 26, 2024
Ultrasound Scanner Computerized 400 (1)
Ultrasound-based deep learning models aid thyroid nodule prediction
By Amerigo Allegretto
A deep learning-based framework incorporating ultrasound images and clinical data can help in thyroid nodule prediction.
November 25, 2024
Thyroid 400
Elastography shows tissue stiffness in athletes with low-back pain
By Amerigo Allegretto
Shear-wave elastography shows tissue stiffness in athletes with low-back pain, which could help guide rehabilitation strategies.
November 22, 2024
Back Pain 400
Nomogram model predicts malignancy risk in ovarian masses
By Amerigo Allegretto
A nomogram model based on O-RADS ultrasound findings and clinical and lab indicators can predict malignancy risk in adnexal cystic-solid masses.
November 19, 2024
Ovarian Cancer Social
AI-enabled CCTA on par with IVUS for plaque quantification
By Kate Madden Yee
An AI-powered automated plaque quantification tool for coronary CT angiography (CCTA) performs on par with intravascular ultrasound (IVUS) for quantifying heart plaque volume and characterizing plaque.
November 14, 2024
Heart Plaque
Ultrasound-guided nerve blocks safe for emergency pain management
By Amerigo Allegretto
Ultrasound-guided nerve blocks (UGNBs) performed by emergency clinicians could be safe for pain management.
November 13, 2024
Emergency 400
Thermal ablation effective long term in patients with thyroid cancer
By Will Morton
Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.
November 7, 2024
Thyroid Cancer
Could cranial ultrasound sub for brain MRI in imaging infants?
By Amerigo Allegretto
Cranial ultrasound could have utility for imaging infants with hypoxic-ischemic encephalopathy.
November 6, 2024
Baby Bottle
Ultrasound nonmass breast lesion features may signal malignancy
By Amerigo Allegretto
Some nonmass breast lesion characteristics on ultrasound exams can be considered suspicious for malignancy at screening ultrasound.
November 5, 2024
Images depict a 43-year-old woman with a malignant nonmass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic nonmass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected nonmass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
ChatGPT demonstrates mixed results in assigning BI-RADS categories
By Amerigo Allegretto
ChatGPT achieves modest accuracy when assigning BI-RADS scores for mammograms and breast ultrasound exams.
November 1, 2024
Chat Gpt 400
ABUS screening improves breast cancer screening in low-resource areas
By Amerigo Allegretto
Automated breast ultrasound (ABUS) with remote reading may improve access to breast cancer screening and early detection in low-resource settings.
October 29, 2024
Ultrasound Breast 400
Ukraine's top pediatric hospital rebuilds after bomb attack
By Philip Ward
Radiology staff at the Ohmatdyt Children's Hospital in Kyiv are making steady progress with their plan to restore normal service after a devastating missile attack.
October 25, 2024
Thanks to the support of the global imaging community, radiology staff at the Ohmatdyt can now look forward to restoring normal service.
Page 1 of 512
Next Page